Skip to main content
Avicanna Inc. logo

Avicanna Inc. — Investor Relations & Filings

Ticker · AVCN ISIN · CA05368K1003 LEI · 254900AUQ4URGWO3FN90 TSX Manufacturing
Open in API
Filings indexed 484 across all filing types
Latest filing 2024-04-26 Capital/Financing Update
Country CA Canada
Listing TSX AVCN

About Avicanna Inc.

https://www.avicanna.com/

Avicanna is a commercial-stage international biopharmaceutical company focused on the advancement and commercialization of evidence-based, cannabinoid-based products for the global medical and pharmaceutical markets. The company operates through four commercial pillars: Medical Cannabis Products (RHO Phyto™), a Medical Cannabis Care Platform (MyMedi.ca), a Pharmaceutical Pipeline, and Active Pharmaceutical Ingredients (Aureus Santa Marta™). Avicanna leverages an industry-leading scientific platform, including R&D collaborations with academic institutions and a robust IP portfolio, resulting in over 50 proprietary commercialized SKUs.

Recent filings

Filing Released Lang Actions
Material change report (amended) - English.pdf
Capital/Financing Update Classification · 95% confidence The document is titled 'FORM 51-102F3 MATERIAL CHANGE REPORT' and details a specific material change event: the closing of a non-brokered private placement offering with details on units sold, pricing, warrants, and finders' fees. It includes the date of the material change and contact information for an executive officer. The content focuses on a financing event rather than a full financial report or earnings release. The document length is 2291 characters, which is relatively short and specific to a capital raising event. This matches the definition of a Capital/Financing Update (CAP) filing, which covers updates on company fundraising and financing activities. Therefore, the correct classification is CAP with high confidence.
2024-04-26 English
Material change report - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a FORM 51-102F3 Material Change Report filed by Avicanna Inc. It details a non-brokered private placement financing transaction, including the number of units issued, price, warrants, and finders' fees. The document is short (2092 characters) and focuses on a financing event rather than a full financial report. It is not an annual or interim report, nor an earnings release or management discussion. The content fits the definition of a Capital/Financing Update (CAP), which covers company fundraising and financing activities. Therefore, the correct classification is CAP with high confidence.
2024-04-26 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2024-04-26 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is an announcement about the closing of a non-brokered private placement financing by Avicanna Inc. It details the number of units sold, the price, the use of proceeds, and the terms of the units and warrants issued. There is no financial statement or detailed financial analysis included, nor is it a transcript, report, or regulatory filing of financial results. The content focuses on capital raising activities and financing terms. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is 7501 characters, which is sufficient for a detailed announcement but does not contain financial statements or management discussion. Hence, the classification is CAP with high confidence.
2024-04-18 English
News release - English.pdf
Regulatory Filings
2024-04-10 English
News release - English.pdf
Annual Report Classification · 95% confidence The document is titled 'Avicanna Reports Full Year 2023 Audited Financial Results' and contains detailed financial data for the full year 2023, including revenue, gross profit, EBITDA, cash flow, and operational highlights. It also discusses acquisitions, product launches, regulatory approvals, and business developments. The presence of audited financial statements and comprehensive financial performance data for the full fiscal year indicates this is a full annual financial report. The document is over 11,000 characters, so it is not a brief announcement or a report publication notice. It is not a quarterly or interim report, nor is it a simple earnings release since it includes audited results and extensive financial details. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-02 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.